Dr. Nik Gravenstein Joins Xhale Assurance, Inc. as Chief Medical Advisor

Dr. Nik Gravenstein Joins Xhale Assurance, Inc. as Chief Medical Advisor

GAINESVILLE, FL October 19, 2017

Xhale Assurance, Inc., a medical technology company developing and commercializing unique monitoring solutions for the pharmaceutical and healthcare industries, announced today the appointment of Dr. Nik Gravenstein to the role of Chief Medical Advisor.

For Dr. Nikolaus Gravenstein, upholding high standards is a family tradition stretching back 45 years. The University of Florida, College of Medicine recruited Gravenstein’s father, Joachim Gravenstein, to begin the Department of Anesthesiology in 1958. Dr. Nikolaus Gravenstein is the Jerome H. Modell Professor of Anesthesiology, as well as a Professor of Neurosurgery and Professor of Periodontology at the University of Florida. He received his medical degree from the University of Florida, where he also completed his residency and fellowship. His internship in surgery was completed at the University of Minnesota.

Dr. Gravenstein’s work has led to seven patented innovations, including two monitors for carbon dioxide and a noninvasive method for determining hematocrit and blood levels of hemoglobin and oxygen. He has edited and co-edited multiple textbooks, contributed chapters to 28 books, and has written or contributed to more than 80 articles for refereed publications. Dr. Gravenstein has received much honorable recognition, including being named as Outstanding Specialist by the Consumer Referral Guide “The Best Doctors in America: Southeast Region.”

About Xhale Assurance

Xhale Assurance, Inc. was founded in 2005 on technology licensed from the University of Florida. It is focused on developing a patient monitoring technology designed to improve and expand the use of conventional pulse oximetry used in hospitals and other clinical settings to monitor critical patient parameters, as well as to increase the number of parameters which can be measured. Xhale’s first product based on this technology, the Assurance® Nasal Alar SpO2™ pulse oximetry sensor, that received marketing clearance in the United States, is a disposable sensor placed on a patient’s nasal ala which transmits heart rate and blood oxygenation information to an oximetry monitor.

For more information, please visit

www.xhale.com/assurance or contact the company at